|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
10/19/2005 5:11:57 PM
NEW YORK, July 20, 2005 (PRIMEZONE) -- Advanced Plant Pharmaceuticals, Inc. (OTCBB:APPI) and its majority owned subsidiary, Mazal Plant Pharmaceuticals Inc. ("Mazal"), announced today that Akid Corporation ("Akid"), a Colorado corporation, acquired the entire APPI ownership interest of 7,000,000 shares of the common stock of Mazal, a Delaware corporation, for 20 million Akid shares. The 7 million shares acquired by Akid represent 68.5% of the issued and outstanding shares of Mazal. In exchange, Akid has agreed to issue to APPI a total of 20,000,000 shares of common stock of Akid. Upon this issuance, which is partially subject to Akid increasing its authorized capital, APPI will have approximately 68.5% of the issued and outstanding common shares of Akid. In turn, Akid will hold a majority of the issued and outstanding shares of Mazal.
|
|
|
|
|
|
|
|
|
|
|